Data: 08/08/2026
Total encontrado: 33
1/33Câncer
Petrella S, Machado LD, Machado JC, Juliano Y, Verreschi ITN, Simões MJ. Determination of serum levels of estrogen, progesterone, lh and fsh of athymic nude rats in the proestrus and metestrus phases of the estrous cycle. Acta Oncológica Brasileira, São Paulo: Fundação Antônio Prudente (menção de responsabilidade), v.16, n.3, p. 99-103, 1996. ISSN 0100-3127.

Disponível em: http://accamargo.phlnet.com.br/Acta/AOB199616(3)p.99-103.pdf

RATS; NUDE; ESTRUS; LH; FSH; ESTROGENS; PROGESTERONE


2/33US=22 / Câncer
Brenner DE. Drugs for chemoprevention. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 626-35.

MEDICAMENTOS ANTI INFLAMATORIOS; ANTI-INFECCAO; HELICOBACTER PYLORI; SELECAO DE ESTROGEN RECEPTORES MODULADORES; INIBIDORES DE AROMATASE; SINAIS DE TRANSDUCAO MODIFICADA; EFLORNITINA; RECEPTORES E FATOR DE CRESCIMENTO


3/33US=22-A / Câncer
Slingluff Jr CL, Flaherty K, Rosenberg SA, Read PW. Cutaneous melanoma. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 1897-1951.

BIOLOGIA DO MELANOMA CUTANEO; EPIDEMIOLOGIA; INCIDENCIA; MELANOMA INFANTIL, CRIANCAS E NEONATAL; DISTRIBUICAO ANATOMICA; FATORES DE RISCO PARA MELANOMA; RADIACAO TERAPEUTICA; ESTROGEN E GRAVIDEZ; PREVENCAO; PROTECAO SOLAR; CARACTERISTICAS DO MELANOMA PRIMARIO; BIOPSIA; SUBTIPOS DE MELANOMA: HISTOLOGIA E FATORES FAMILIARES; FATORES PROGNOSTICOS/ MELANOMA PRIMARIO; INVASAO PROFUNDA; ULCERACAO; TAXA MITOTICA; DEFINICAO DE MARGENS P/ INCISAO DE MELANONMA CUTANEO PRIMARIO; CIRURGIA E ESTADIAMENTO DE NODULOS REGIONAIS; SELECAO DE PACIENTES P/ BIOPSIA LINFONODO SENTINELA; MELANOMA PRIMARIO DE MEMBRANA MUCOSA; IMUNOTERAPIA ESPECIFICO; CIRURGIA PARA METASTASES A DISTANCIA; QUIMIOTERAPIA COMBINADA


4/33US=22-A / Câncer
Ofman US, Kingsberg SA, Nelson CJ. Sexual problems. In: DeVita Jr V, Lawrence TS, Rosenberg AS. DeVita, Hellman, and Rosenberg's cancer: principles & practice of oncology. 8ªed. Philadelphia: Lippincott Willians & Wilkins, 2008. p. 2804-17.

DISFUNCAO SEXUAL; CANCER DE MAMA; CIRURGIA; QUIMIOTERAPIA; RECEPTORES MODULADORES SELETIVOS DE ESTROGEN; RADIOTERAPIA; CANCER GINECOLOGICO; CANCER DO COLO UTERINO; CANCER VULVAR; CANCER DO ENDOMETRIO; CANCER UTERINO; CANCER DO OVARIO; MENOPAUSA; CANCER PROSTATA; CIRURGIA; TERAPIA HORMONAL; CANCER DE BEXIGA; CANCER DE BEXIGA EM HOMENS; CANCER DE BEXIGA EM MULHERES; CANCER TESTICULAR; CANCERES DE CABECA E PESCOCO; CANCER COLO RETAL; CANCERES EM CRIANCAS


5/33Câncer
Rocha RM, Miller K, Soares F, Vassallo J, Shenka N, Gobbi H. The use of the immunohistochemical biotin-free visualization systems for estrogen receptor evaluation of breast Cancer. Applied Cancer Research, São Paulo: Tecmedd, v.29, n.3, p. 112-7, 2009. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR2009293p.112-7.pdf

IMMUNOHISTOCHEMISTRY; BREAST NEOPLASMS; ESTROGEN RECEPTOR


6/33Câncer
Safar ASS, Pelloso SM, Wielewski S, Kasimerczak AR, de Lima ANZ, ITS Previdelli. Immunohistochemical study of ER, PR and HER2 expression in obese and non-obese menopausal women with breast cancer. Applied Cancer Research, São Paulo: Tecmedd, v.29, n.3, p. 125-8, 2009. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR2009293p.125-8.pdf

BREAST NEOPLASMS; OBESITY; MENOPAUSE; IMMUNOHISTOCHEMICAL; ESTROGEN REPLACEMENT THERAPY


7/33Câncer
Balancin ML, Ramalho LNZ. Wandering Spleen, Splenic Mesothelial Cyst and Angiomyolipoma:A New Syndrome or Coinciding Distinct Entities Reactive to Estrogen?. Applied Cancer Research, São Paulo: Tecmedd, v.30, n.1, p. 232-5, 2010. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br/applied/ACR2010v301p.232-235.pdf

WANDERING SPLEEN; DERMOID CYST; HORMONE-DEPENDENT NEOPLASMS; ANGIOMYOLIPOMA; PREGNANCY; ESTROGEN


8/33US=25 / Mama
Schiff R, Osborne CK, Fuqua SAW. Clinical aspects of estrogen and progesterone receptors. In: Harris JR, Lippman ME, Morrow M, Osborne CK. Diseases of the breast. 4ªed. Philadelphia: Lippincott Williams & Wilkins, 2010. p. 408-30. ISBN 978-0-7817-9117-5.

RECEPTORES DE ESTROGENIO E PROGESTERONA; CANCER DE MAMA. RECEPTORES; TERAPIA ENDOCRINO


9/33US=45 / Clín/Médica
McCarty MF. Isoflavones made simple - agonist activity for the beta-type estrogen receptor may mediate their health benefits. In: Watson RR, editor. Complementary and alternative therapies in the agind population. Amsterdan: Elsevier, 2009. p. 475-522. ISBN 978-0-12-374228-5.

ISOFLAVONAS; ATIVIDADE AGONISTA PARA O RECEPTOR DE ESTROGENIO BETA-TIPO; SOJA; ISOFLAVONAS; GENISTEINA; ERALPHA; ERBETA


10/33US=50 / Câncer
Baehner FL. Estrogen receptor-positive breast cancer: tradicional prognostics, molecular pathology: a new breast cancer taxonomy and 21st century personalized prognostic and predictive assays. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 465-95. ISBN 978-1-60327-086-1.

PERFIL DE EXPRESSAO DE GENE; QRT-PCR; CANCER DE MAMA; CANCER DE MAMA TIPO BASAL; CANCER DA MAMA HER2 TIPO; CANCER DE MAMA TIPO LUMINAL; PROGNOSTICO; PREDITIVO


11/33US=85 / Biol/Mol
Kim JY, Park HD, Park E, Chon JW, Park YK. Growth-inhibitory and proapoptotic effects of alpha-linolenic acid on estrogen-positive breast cancer cells: second look at n-3 fatty acid. In: Diederich M. Natural compounds and their role in apoptotic cell signaling pathways. Boston: Blackwell, 2009. p. 190-5. (Annals of the New York Academy of Sciences Vol 1171) ISBN 978-1-57331-737-5.

ALFA LINOLENICO-ACIDO; CELULAS CANCEROSAS DA MAMA; BAX; BCL-2; CITOCROMO C; CASPASE-3; POLI POLIMERASE (ADP-ROBOSI)


12/33US=96 / Biol/Mol
Sepkovic DW, Bradlow HL. Estrogen hydroxylation - The good and the bad. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 57-67. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

DIM; I3C; CIN; DEHP; AIF; HPV; HIDROXILACAO ESTROGENIO; DIINDOLYLMETHANE; INDOL-3-CARBINOL; CITOCROMOS; POLIMORFISMOS GENETICOS; ISOFLAVONAS DA SOJA; PAPILOMATOSE LARINGEA; NEOPLASIA CERVICAL INTEREPITHELIAL; -DI (2-ETHYLHEXY1) PHTHALETE; FATOR INIBITORIO DOS ADIPOCITOS; VIRUS DO PAPILOMA HUMANO


13/33US=96 / Biol/Mol
Parl FF, Dawling S, Roodi N, Crooke PS. Estrogen metabolism and breast cancer: a risk model. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 68-75. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ESTROGENIO; METABOLISMO; CANCER DE MAMA; RISCO; GENOTIPO; MODELO


14/33US=96 / Biol/Mol
Pasqualini JR. Estrogen sulfotransferases in breast and endometrial cancers. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 88-98. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ESTROGENIOS; SULFOTRANSFERASE; PEITO; ENDOMETRIO; CANCER; ESTROGENIO; SULT; EST


15/33US=96 / Biol/Mol
Hong Y, Li H, Yuan YC, Chen S. Molecular characterization of aromatase. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 112-20. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

AROMATASE; AROMATASE INHIBITORS; BREAST CANCER; COMPUTER MODELING; ESTROGEN; STRUCTURE-FUNCTION STUDIES; NADPH-CYTOCHROME P450 REDUCTASE


16/33US=96 / Biol/Mol
Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J, Yue W. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 132-40. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ESTROGENIO; 4-OH-ESTRADIOL; CANCER DE MAMA; GENOTOXICIDADE; EFEITOS


17/33US=96 / Biol/Mol
Ellem SJ, Risbridger GP. The dual, opposing roles of estrogen in the prostate. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 174-86. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ESTROGENIO; PROSTATA; AROMATASE; PROSTATITE; ER-&*945;; ER-ß


18/33US=96 / Biol/Mol
Márquez-Garbán DC, Chen HW, Goodglick L, Fishbein MC, Pietras RJ. Targeting aromatase and estrogen signaling in human non-small cell lung cancer. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 194-205. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

NSCLC; CYP19; EGFR; NAO-PEQUENAS CELULAS DE PULMAO; AROMATASE; RECEPTOR DE ESTROGENO; RECEPTOR DO FATOR DE CRESCIMENTO EPIDERMICO; RECEPTOR DO FATOR DE CRESCIMENTO ENDOTELIAL VASCULAR; ANASTRAZOLE; EXEMESTANO; FULVESTRANT; VANDETANIB


19/33US=96 / Biol/Mol
Granata OM, Traina A, Ramirez S, Campisi I, Zarcone M, Amodio R, Polito LM, Carruba G. Dietary enterolactone affects androgen and estrogen levels in healthy postmenopausal women. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 232-6. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

DIETA MEDITERRANEA; ENTEROLACTONA; INSULINA; TESTOSTERONA; ANDROSTERONA; ETIOCOLANOLONE; INTERVENCAO DIETETICA


20/33US=96 / Biol/Mol
Campisi I, Granata OM, Cocciadiferro L, Calabrò M, Polito LM, Carruba G. 16¦Á-hydroxyestrone inhibits estrogen sulfotransferase activity in human liver cancer cells. In: Bradlow KL, Carruba G. Steroid enzymes and cancer. Boston: Blackwell, 2009. p. 237-42. (Annals of the New York Academy of Science,v.155) ISBN 9978-1-57331-745-0.

ESTROG¨ºNIO SULFOTRANSFERASE; MODULADORES SELETIVOS DE RECEPTOR DE ESTROG¨ºNIO; SERMS; 16¦A-OHE1; C¨¦LULAS HEPG2


Primeira | Anterior | Próxima | Última